Produktname:6,8-Dioxo-5,7-diazaspiro[3.4]octane-2-carboxylic acid

IUPAC Name:6,8-dioxo-5,7-diazaspiro[3.4]octane-2-carboxylic acid

CAS:1186202-25-4
Molekulare Formel:C7H8N2O4
Reinheit:95%
Katalognummer:CM139461
Molekulargewicht:184.15

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM139461-1g in stock Şǫȯ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:1186202-25-4
Molekulare Formel:C7H8N2O4
Schmelzpunkt:-
SMILES-Code:O=C(C1CC2(NC(NC2=O)=O)C1)O
Dichte:
Katalognummer:CM139461
Molekulargewicht:184.15
Siedepunkt:
Mdl-Nr.:MFCD20644543
Lagerung:Store at 2-8°C.

Category Infos

Cyclobutanes
The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.
Imidazolidines
Imidazolidine is a heterocyclic compound (CH2)2(NH)2CH2. The parental imidazolidines are less studied, but related compounds substituted on one or both nitrogen centers are more common. Generally, they are colorless, polar, basic compounds. Imidazolidines are examples of cyclic 5-membered general amines. Imidazolidine derivatives are key components in the development of bioactive compounds for the treatment of various diseases, especially Chagas disease. In fact, other studies have shown that imidazoline-2,4-diones have a wide range of pharmacological activities, including anticonvulsant, antiarrhythmic, and antiparasitic.
imidazolidine supplier
As a imidazolidine supplier,we sincerely welcome the new and old friends from home and abroad to synergize with our company and share the benefits and opportunities.